← Back to Search

Decision Aid Tool for Colorectal Cancer Screening

N/A
Recruiting
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between the ages of 75 and 85 years
Be older than 65 years old
Must not have
Patients who do not have the capacity to participate
Patients with a history of invasive/non-invasive colorectal cancer.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trialwill study if a new decision aid tool can help seniors make better decisions about colorectal cancer screening. It will test if it can increase knowledge and engagement, and if it's acceptable.

Who is the study for?
This trial is for adults aged 75-85 with low health literacy, who feel somewhat to not at all confident filling out medical forms. They should have a community college education or less and no history of colorectal cancer, dementia, or lack the capacity to participate.
What is being tested?
The study tests if a new decision aid pamphlet helps these older adults decide about colorectal cancer screening. It looks at their intention to get screened based on life expectancy and risk factors, knowledge increase, engagement in shared decision-making (SDM), and acceptance of the aid.
What are the potential side effects?
Since this trial involves educational materials rather than medications or invasive procedures, there are no direct physical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 75 and 85 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to participate in the trial due to my condition.
Select...
I have a history of colorectal cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in CRC Screening Intentions
Secondary study objectives
Change in Knowledge
Feelings of anxiety when reading the decision aid
Feelings of usefulness of the decision aid
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Home Safety PamphletExperimental Treatment1 Intervention
Stratifying by sex, 30 will be randomized to receive the home safety information at the visit.
Group II: CRC DAExperimental Treatment1 Intervention
Stratifying by sex, 30 participants will be randomized to receive the CRC DA pamphlet.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,726,988 Total Patients Enrolled
Abramson Cancer Center at Penn MedicineLead Sponsor
418 Previous Clinical Trials
464,062 Total Patients Enrolled
Simmons UniversityLead Sponsor

Media Library

Home Safety Pamphlet Clinical Trial Eligibility Overview. Trial Name: NCT04748380 — N/A
Colorectal Cancer Research Study Groups: Home Safety Pamphlet, CRC DA
Colorectal Cancer Clinical Trial 2023: Home Safety Pamphlet Highlights & Side Effects. Trial Name: NCT04748380 — N/A
Home Safety Pamphlet 2023 Treatment Timeline for Medical Study. Trial Name: NCT04748380 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top